万方数据
万方数据
万方数据
万方数据
万方数据
万方数据
万方数据
万方数据
万方数据
万方数据
万方数据
万方数据
万方数据
万方数据
万方数据
万方数据
慢性乙型肝炎防治指南(2010年版)
作者：中华医学会肝病学分会， 中华医学会感染病学分会， Chinese Society of Hepatology，Chinese Society of Infectious Diseases
作者单位：
刊名：
胃肠病学
英文刊名：CHINESE JOURNAL OF GASTROENTEROLOGY
年，卷(期)：2011,16(6)
被引用次数：26次
参考文献(114条)
1.中华医学会肝病学分会;中华医学会感染病学分会慢性乙型肝为防治指南[期刊论文]-中华肝脏病杂志 2005(12)
2.Seeger C;Mason WS Hepatitis B virus biology[外文期刊] 2000(01)
3.Scaglioni PP;Melegari M;Wands JR Biologic properties of hepatitis B viral genomes with mutations
in the precore promoter and precore open reading frame[外文期刊] 1997(02)
4.Tran TT;Trinh TN;Abe K New complex recombinant genotype of hepatitis B virus identified in Vietnam [外文期刊] 2008(11)
5.Olinger CM;Jutavijittum P;Hubschen JM Possible new hepatitis B virus genotype,southeast Asia[外文期刊] 2008(11)
6.Chu CJ;Hussain M;Lok AS Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B vinis genotype C[外文期刊] 2002(07)
7.Chu CM;Liaw YF Cenotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B:a longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baseline[外文期刊] 2005(03)
8.Yu MW;Yeh SH;Chen PJ Hepatitis B virus genotype and DNA level and hepatocellular carcinoma:a prospective study in men[外文期刊] 2005(04)
9.Zhang HW;Yin JH;Li YT Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai,China[外文期刊] 2008(12)
10.Hou J;Schilling R;Janssen HL Genetic characteristics of hepatitis B virus genotypes as a factor for interferon-induced HBeAg clearance[外文期刊] 2007(08)
11.Jardi R;Rodriguez-Frias F;Schaper M Analysis of hepatitis B genotype changes in chronic hepatitis
B infection:Influence of antiviral therapy[外文期刊] 2008(05)
12.Liu CJ;Kao JH Genetic variability of hepatitis B virus and response to antiviral therapy[外文期刊] 2008(05)
13.Ganem D;Prince AM Hepatitis B virus infectionnatural history and clinical consequences[外文期刊] 2004(11)
14.World Health Organization Hepatitis B,(Revised August 2008) 2010
15.Liang X;Bi S;Yang W Epidemiological serosurvey of hepatitis B in China-declirung HBV prevalence due to hepatitis B vaccination[外文期刊] 2009(47)
16.Liang X;Bi S;Yang W Evaluation of the impact of hepatitis B vaccination among children born
during 1992-2005 in China 2009(01)
17.Lu FM;Zhuang H Management of hepatitis B in China[期刊论文]-Chinese Medical Journal 2009(01)
18.Mast EE;Weinbaum CM;Fiore AE Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC) A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States:recommendations of the Advisory Committee on Immunization Practices (ACIP) Part Ⅱ:immuruzation of adults 2006(RR-16)
19.World Health Organization Hepatitis B 2010
https://www.doczj.com/doc/1f9343289.html,i CL;Ratziu V;Yuen MF Viral hepatitis B[外文期刊] 2003(9401)
21.Liaw YF Natural history of chronic hepatitis B virus infection and Iong-term outcome under treatment 2009(Suppll)
22.Hui CK;Leung N;Yuen ST Hong Kong Liver Fibrosis Study Croup.Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase[外文期刊] 2007(02)
23.McMahon BJ The natural history of chronic hepatitis B virus infection[外文期刊] 2009(5 Suppl)
24.Liaw YF Hepatitis flares and hepatitis B e antigen seroconversion:implication in anti-hepatitis B virus therapy[外文期刊] 2003(03)
25.Chu CM;Hung SJ;Lin J Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum anunotransferase levels[外文期刊] 2004(12)
26.Fattovich G;Brollo L;Alberti A Long-term follow up of anti-HBe-positive chronic active hepatitis B[外文期刊] 1988(06)
27.Brunetto MR;Oliveri F;Rocca G Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen[外文期刊] 1989(02)
28.Di Marco V;Lo Iacono O;CammA C The long-term course of chronic hepatitis B[外文期刊] 1999(01)
29.Chu CM;Liaw YF Hepatitis B virus-related cirrhosis:natural history and treatment[外文期刊]
2006(02)
30.Chen YC;Chu CM;Yeh CT Natural course following the onset of cirrhosis in patients with chronic hepatitis B:a long-term follow-up study[外文期刊] 2007(01)
31.Hsu YS;Chien RN;Yeh CT Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B[外文期刊] 2002(06)
32.Chou YC;Yu MW;Wu CF Temporal relationship between hepatitis B virus enhancer Ⅱ/basai core promoter sequence variation and risk of hepatocellular carcinoma[外文期刊] 2008(01)
33.Chen CJ;Yang HI;Su J REVEAL-HBV Study Group.Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level[外文期刊] 2006(01)
34.Yang HI;Lu SN;Liaw YF Ttuwan CommunityBased Cancer Screening Project Group.Hepatitis B e antigen and the risk of hepatocellular carcinoma[外文期刊] 2002(03)
35.LIoeje UH;Yang HI;Su J Risk Evaluation of Viral Load Elevation and Associated Liver
Disease/Cancer-In HBV (the REVEAL-HBV) Study Croup.Ptedicting cirrhosis risk based on the level of circulating hepatitis B viral load[外文期刊] 2006(03)
36.Tai DI;Chen CH;Chang TT Eight-year nationwide survival analysis in relatives of patients with
hepatocellular carcinoma:role of viral infection[外文期刊] 2002(06)
37.中国疾病预防控制中心乙型肝炎疫苗儿童计划免疫技术管理规程(试行) 2002
38.夏围良;龚健;王继杰重组乙型肝炎疫苗阻断乙型肝炎病毒母婴传播方案的保护效果评价[期刊论文]-中华流行病学杂志 2003(05)
39.邢玉兰;龚晓红;周绍莲阻断围产期母婴传播最佳免疫方案的研究 1990
40.Center for Disease Prevention and Control Breastfeeding 2010
41.World Health Organization Hepatitis B and breastfeeding 2010
42.Zanetti AR;Mariano A;RomanòL Study Group.Long-term immunogenicity of hepatitis B vaccination and policy for booster:an Italian multicentre study[外文期刊] 2005(9494)
43.John TJ;Cooksley G Steering Committee for the Prevention and Control of Infectious Diseases in Asia.Hepatitis B vaccine boosters:is there a clinical need in high endemicity populations[外文期刊] 2005(01)
44.U.S.Public Health Service Updated U.S.public health service guidelines for the management of occupational xposures to HBV,HCV,and HIV and recommendations for postexposure prophylaxis 2001(RR-11)
45.中华医学会传染病与寄生虫病学分会;中华医学会肝病学分会病毒性肝炎防治方案[期刊论文]-中华肝脏病杂志 2000(06)
46.Pawlotsky JM;Dusheiko G;Hatzakis A Virologic morutoring of hepatitis B virus therapy in clinical trials and practice:recommendations for a standardized approach[外文期刊] 2008(02)
47.Shaheen AA;Wan AF;Myers RP FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis:a systematic review of diagnostic test accuracy[外文期刊] 2007(11)
48.Scott DR;Levy MT Liver transient elastography (Fibroscan):a place in the management algorithms of chronic viral hepatitis[外文期刊] 2010(01)
49.LDk AS;McMahon BJ Chronic hepatitis B:update 2009[外文期刊] 2009(03)
50.Lin SM;Yu ML;Lee CM Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma[外文期刊] 2007(01)
51.Manesis EK;Hadziyannis SJ Interferon alpha treatment and retreatment of hepatitis B e antigen-negative chronic hepatitis B[外文期刊] 2001(01)
https://www.doczj.com/doc/1f9343289.html,u GK;Piratvisuth T;Luo KX Peginterferon Alfa2a HBeAg-Positive Chronic Hepatitis B Study Group.Peginterferon Alfa-2a,lamivudine,and the combination for HBeAg-positive chronic hepatitis B[外文期刊] 2005(26)
53.Piratvisuth T;Lau G;Chao YC Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B 2008(01) 54.Chan HL;Leung NW;Hui AY A randomized,controlled trial of combination therapy for chronic
hepatitis B:comparing pegylated interferon-alpha2b and lanuvudine with lanuvudine alone[外文期刊] 2005(04)
55.Flink HJ;van Zonneveld M;Hansen BE HBV 9901 Study Group.Treatment with Peg-interferon alpha-2b
for HBeAg-positive chronic hepatitis B:HBsAg loss is associated with HBV genotype[外文期刊] 2006(02)
56.Buster EH;Flink HJ;Cakaloglu Y Sustained HBeAg and HBsAg Ioss after long-term follow-up ofHBeAg-positive patients treated with peginterferon alpha2b[外文期刊] 2008(02)
57.Marcellin P;Lau GK;Bonino F Peginterferon Alfa2a HBeAg-Negative ChroNic Hepatitis B Study Croup.Peginterferon alfa-2a alone,lanuvudine alone,and the two in combination in patients with HBeAg-negative chronic hepatitis B[外文期刊] 2004(12)
58.Marcellin P;Boniuno F;Lau CK Peginterferon alfa2a in HBeAg-negative Chronic Hepatitis B Study Group.Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alpha2a[外文期刊] 2009(07)
59.Lok AS;McMahon BJ Chronic hepatitis B[外文期刊] 2007(02)
60.Keeffe EB;Dieterich DT;Han SH A treatment algorithm for the management of chronic hepatitis B virus infection in the United States:an update[外文期刊] 2006(08)
61.Fried MW;Piratvisuth T;Lau GK HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B[外文期刊] 2008(02)
62.response to pegylated interferon alfa-2a in HBeAgnegative patients[外文期刊] 2009(04)
63.Brunetto MR;Moriconi F;Bonino F Hepatitis B virus surface antigen levels:a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B[外文期刊] 2009(04)
64.Lok AS;Lai CL;Leung N Long-term safety of lamivudine treatment in patients with chronic hepatitis B[外文期刊] 2003(06)
https://www.doczj.com/doc/1f9343289.html,i CL;Chien RN;Leung NW A one-year trial of lamivudine for chronic hepatitis https://www.doczj.com/doc/1f9343289.html, Hepatitis Lamivudine Study Group[外文期刊] 1998(02)
66.Liaw YF;Leung NW;Chang TT Effects of extended lamivudine therapy in Asian patients with chronic hepatitis https://www.doczj.com/doc/1f9343289.html, Hepatitis Lamivudine Study Group[外文期刊] 2000(01)
67.Dienstag JL;Schiff ER;Wright TL Lamivudine as initial treatment for chronic hepatitis B in the United States[外文期刊] 1999(17)
68.Chien RN;Liaw YF;Atkins M Pretherapy alanine transaminase level as a determinant for hepatitis B
e antigen seroconversion during lamivudine therapy inpatients with chroruc hepatitis https://www.doczj.com/doc/1f9343289.html,n Hepatitis Lamivudine Trial Croup[外文期刊] 1999(03)
69.Dienstag JL;Goldin RD;Heathcote EJ Histological outcome during long-term lanuvudine therapy[外文期刊] 2003(01)
70.Liaw YF;Sung JJ;Chow WC Cirrhosis Asian Lamivudine Multicentre Study https://www.doczj.com/doc/1f9343289.html,mivudine for
patients with chronic hepatitis B and advanced liver disease[外文期刊] 2004(15)
71.Villeneuve JP;Condreay LD;Willems B Lamivudine treatment for decompensated cirrhosis resulting from chronic hepatitis B[外文期刊] 2000(01)
72.Perrillo RP;Wright T;Rakela J Lanuvudine North American Transplant Group.A multicenter United StatesCanadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B[外文期刊] 2001(02)
73.Hann HW;Fontana RJ;Wright T United States Lamivudine Compassionate Use Study Group,A United States compassionate use study of lamivudine treatment in nontransplantation candidates with